Literature DB >> 12743312

Multiple Epstein-Barr virus infections in healthy individuals.

Dennis M Walling1, Abigail L Brown, Wiguins Etienne, Wendy A Keitel, Paul D Ling.   

Abstract

We employed a newly developed genotyping technique with direct representational detection of LMP-1 gene sequences to study the molecular epidemiology of Epstein-Barr virus (EBV) infection in healthy individuals. Infections with up to five different EBV genotypes were found in two of nine individuals studied. These results support the hypothesis that multiple EBV infections of healthy individuals are common. The implications for the development of an EBV vaccine are discussed.

Entities:  

Keywords:  NASA Discipline Regulatory Physiology; NASA Program Biomedical Research and Countermeasures; Non-NASA Center

Mesh：

Substances：

Year:  2003        PMID： 12743312      PMCID： PMC155020          DOI： 10.1128/jvi.77.11.6546-6550.2003

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  46 in total

1.  Evidence for trafficking of Epstein-Barr virus strains between hairy leukoplakia and peripheral blood lymphocytes.

Authors:  Joel M Palefsky; Jennifer Berline; Deborah Greenspan; John S Greenspan
Journal:  J Gen Virol       Date:  2002-02       Impact factor: 3.891

2.  Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains.

Authors:  J M Brooks; D S Croom-Carter; A M Leese; R J Tierney; G Habeshaw; A B Rickinson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Infectious mononucleosis and Epstein-Barr virus in childhood.

Authors:  D Tamir; A Benderly; J Levy; E Ben-Porath; A Vonsover
Journal:  Pediatrics       Date:  1974-03       Impact factor: 7.124

4.  Observations on childhood infections with the Epstein-Barr virus.

Authors:  G Henle; W Henle
Journal:  J Infect Dis       Date:  1970-03       Impact factor: 5.226

5.  Infectious mononucleosis in a general population.

Authors:  C W Heath; A L Brodsky; A I Potolsky
Journal:  Am J Epidemiol       Date:  1972-01       Impact factor: 4.897

6.  Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains.

Authors:  R H Edwards; F Seillier-Moiseiwitsch; N Raab-Traub
Journal:  Virology       Date:  1999-08-15       Impact factor: 3.616

7.  Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay.

Authors:  Diane Sitki-Green; Rachel H Edwards; Jennifer Webster-Cyriaque; Nancy Raab-Traub
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study.

Authors:  Paul D Ling; John A Lednicky; Wendy A Keitel; David G Poston; Zoe S White; RongSheng Peng; Zhensheng Liu; Satish K Mehta; Duane L Pierson; Cliona M Rooney; Regis A Vilchez; E O'Brian Smith; Janet S Butel
Journal:  J Infect Dis       Date:  2003-04-30       Impact factor: 5.226

9.  Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection.

Authors:  Barbara Savoldo; M Helen Huls; Zhensheng Liu; Takayuki Okamura; Hans-Dieter Volk; Petra Reinke; Robert Sabat; Nina Babel; James F Jones; Jennifer Webster-Cyriaque; Adrian P Gee; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

10.  Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriers.

Authors:  Diane Sitki-Green; Mary Covington; Nancy Raab-Traub
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103
View more
  36 in total

Review 1.  Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years.

Authors:  Ralf D Hess
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

Review 2.  Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumors.

Authors:  Shannon Kenney
Journal:  Trans Am Clin Climatol Assoc       Date:  2006

3.  Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology.

Authors:  Pan Liu; Xiaodong Fang; Zizhen Feng; Yun-Miao Guo; Rou-Jun Peng; Tengfei Liu; Zhiyong Huang; Yue Feng; Xiaoqing Sun; Zhiqiang Xiong; Xiaosen Guo; Sha-Sha Pang; Bo Wang; Xiaojuan Lv; Fu-Tuo Feng; Da-Jiang Li; Li-Zhen Chen; Qi-Sheng Feng; Wen-Lin Huang; Mu-Sheng Zeng; Jin-Xin Bei; Yong Zhang; Yi-Xin Zeng
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

4.  Koala and Wombat Gammaherpesviruses Encode the First Known Viral NTPDase Homologs and Are Phylogenetically Divergent from All Known Gammaherpesviruses.

Authors:  Paola K Vaz; Carol A Hartley; Sang-Yong Lee; Fiona M Sansom; Timothy E Adams; Kathryn Stalder; Lesley Pearce; George Lovrecz; Glenn F Browning; Christa E Müller; Joanne M Devlin
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

5.  High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.

Authors:  Eric R Weiss; Galit Alter; Javier Gordon Ogembo; Jennifer L Henderson; Barbara Tabak; Yasin Bakiş; Mohan Somasundaran; Manuel Garber; Liisa Selin; Katherine Luzuriaga
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

Review 6.  The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease.

Authors:  Olivia L Hatton; Aleishia Harris-Arnold; Steven Schaffert; Sheri M Krams; Olivia M Martinez
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

7.  Epstein-Barr virus infection of Langerhans cell precursors as a mechanism of oral epithelial entry, persistence, and reactivation.

Authors:  Dennis M Walling; Autumn J Ray; Joan E Nichols; Catherine M Flaitz; C Mark Nichols
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

8.  Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids.

Authors:  Nicholas Renzette; Mohan Somasundaran; Frank Brewster; James Coderre; Eric R Weiss; Margaret McManus; Thomas Greenough; Barbara Tabak; Manuel Garber; Timothy F Kowalik; Katherine Luzuriaga
Journal:  J Virol       Date:  2014-01-15       Impact factor: 5.103

9.  Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection.

Authors:  Shizuko Harada; Yoshio Kamata; Yasuyuki Ishii; Hiroyuki Eda; Ryo Kitamura; Maya Obayashi; Sayuri Ito; Fumihiko Ban; Jun Kuranari; Haruhiko Nakajima; Tomoko Kuze; Masao Hayashi; Nobuhiko Okabe; Hidenobu Senpuku; Nobuyuki Miyasaka; Yoshiko Nakamura; Hirokazu Kanegane; Kazuo Yanagi
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

10.  Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses.

Authors:  Cagan Gurer; Till Strowig; Fabienne Brilot; Maggi Pack; Christine Trumpfheller; Frida Arrey; Chae Gyu Park; Ralph M Steinman; Christian Münz
Journal:  Blood       Date:  2008-06-02       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.